Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult‐to‐treat patients

The standard therapy for patients with haemophilia is prophylactic treatment with replacement factor VIII (FVIII) or factor IX (FIX). Patients who develop inhibitors against FVIII/FIX face an increased risk of bleeding, and the likelihood of early development of progressive arthropathy, alongside hi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur J Haematol
Main Authors: Ljung, Rolf, Auerswald, Guenter, Benson, Gary, Dolan, Gerry, Duffy, Anne, Hermans, Cedric, Jiménez‐Yuste, Victor, Lambert, Thierry, Morfini, Massimo, Zupančić‐Šalek, Silva, Santagostino, Elena
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2018
Assuntos:
Review Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6936224/
https://ncbi.nlm.nih.gov/pubmed/30411401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ejh.13193
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares